Monopar Therapeutics Inc.

Direct answer

Monopar Therapeutics Inc. is publicly traded on NASDAQ under the ticker MNPR.

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase...

Can you invest in Monopar Therapeutics Inc.?

Yes. Monopar Therapeutics Inc. is publicly traded on NASDAQ under the ticker MNPR.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Monopar Therapeutics Inc.

Detailed equity research is provided by MarketSnap.